IRIS
NG, KIU YAN CHARLOTTE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 387
AS - Asia 335
EU - Europa 49
AF - Africa 4
OC - Oceania 2
Totale 777
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 387
SG - Singapore 197
CN - Cina 138
IT - Italia 14
FI - Finlandia 10
CZ - Repubblica Ceca 6
FR - Francia 6
IE - Irlanda 4
NG - Nigeria 4
DE - Germania 3
AU - Australia 2
BE - Belgio 2
SE - Svezia 2
GB - Regno Unito 1
NL - Olanda 1
Totale 777
Salva come PNG Salva come JPEG
Città #
New York 200
Singapore 142
Shanghai 132
Boardman 35
Wilmington 20
San Mateo 18
Helsinki 10
Abbiategrasso 8
Santa Clara 7
Brno 6
Chandler 6
Lawrence 6
Princeton 6
Fairfield 5
Milan 5
Benin City 4
Dublin 4
Paris 4
Ann Arbor 3
Woodbridge 3
Brussels 2
Hangzhou 2
Montluçon 2
Munich 2
Nanjing 2
Sydney 2
Amsterdam 1
Ashburn 1
Clifton 1
Leawood 1
London 1
Los Angeles 1
Totale 642
Salva come PNG Salva come JPEG
Nome #
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 51
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies 25
Molecular classification of hepatocellular carcinoma: The view from metabolic zonation 24
The protein histidine phosphatase LHPP is a tumour suppressor 17
Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening 17
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes 15
Metaplastic breast carcinoma: more than a special type 14
Breast cancer intratumor genetic heterogeneity: causes and implications 12
Combining two antibodies to define E-cadherin loss of expression in non-lobular breast carcinomas: when less is more 12
Prognostic signatures in breast cancer: correlation does not imply causation 11
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast 11
ESR1 and endocrine therapy resistance: more than just mutations 11
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support 11
Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes 10
Breast cancer intra-tumor heterogeneity 10
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas. 9
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook 9
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses 9
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle 9
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations 9
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis 9
PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma 9
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma 9
Genomic profiling of histological special types of breast cancer 9
Alterations in Homologous Recombination Repair Genes in Prostate Cancer Brain Metastases 9
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression 9
The Role of Long Non-Coding RNAs in Hepatocarcinogenesis 8
Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance 8
The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer 8
Establishing standardized immune phenotyping of metastatic melanoma by digital pathology 8
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes 8
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands 8
Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma 8
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations 8
A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer 7
The role of chronic liver diseases in the emergence and recurrence of hepatocellular carcinoma: an omics perspective. 7
Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein 7
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 7
Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer 7
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples 7
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma 7
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) 7
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases 7
The Genomic Landscape of Male Breast Cancers 7
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer 7
Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights 7
Genomic characterization of metastatic breast cancers 6
DNA methylation landscapes of prostate cancer brain metastasis are shaped by early driver genetic alterations 6
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members 6
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast 6
Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer 6
Chromosomal instability determines taxane response 6
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2(+) Breast Cancer 6
Are acinic cell carcinomas of the breast and salivary glands distinct diseases? 6
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors 6
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 6
Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland 6
Progression from ductal carcinoma in situ to invasive breast cancer: revisited 6
High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations 6
SCIM: universal single-cell matching with unpaired feature sets 6
Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile 6
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations 6
Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion 6
High-resolution genomic profiling of thyroid lesions uncovers preferential copy number gains affecting mitochondrial biogenesis loci in the oncocytic variants 6
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity 6
Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors 5
Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue 5
Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens 5
Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients 5
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma 5
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer 5
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis 5
Radiogenomics Analysis of Intratumor Heterogeneity in a Patient With High-Grade Serous Ovarian Cancer 5
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study 5
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers 5
Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases 5
Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures 5
Genomic evolutionary trajectory of metastatic squamous cell carcinoma of the lung 5
Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer 5
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma 5
The genetic landscape of breast carcinomas with neuroendocrine differentiation 5
Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer 5
Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor 5
The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas 5
Discovery of heterozygous KRT10 alterations in MAUIE cases underlines the importance of regular skin cancer screening in ichthyosis with confetti 5
PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas 5
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer 5
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers 5
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene 5
Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group 5
Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing 5
The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas 5
Genomic landscape of adenoid cystic carcinoma of the breast 5
Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases 5
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers 5
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages 5
PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data 5
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer 4
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships 4
Siglec-7 represents a glyco-immune checkpoint on non-exhausted effector memory CD8+ T cells with high functional and metabolic capacities 4
Totale 784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 1 0 4 7 3 13 8 0 11
2021/202229 0 0 0 9 0 0 0 7 0 1 4 8
2022/202339 12 0 6 1 4 1 0 3 4 6 2 0
2023/2024782 1 3 4 2 0 350 57 56 14 9 112 174
2024/202524 24 0 0 0 0 0 0 0 0 0 0 0
Totale 921